LTX-003

N/A

Report date: 2024/11/12 10:42:48
NME

Base Information

Drug NameLTX-003
Drug Alias NameLTX-003
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionComplement system proteins modulators
TargetsComplement system proteins
Therapy Area/IndicationsGeographic AtrophyFrontotemporal DementiaAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLeal Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesLeal Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsGeographic AtrophyFrontotemporal DementiaAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A